These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1712447)

  • 1. [Use of zinc and parlodel for treatment of physical and sexual development retardation in kidney diseases and rheumatoid arthritis].
    Kukhtevich AV; Ermolenko VM; Adnoral SA; Daminov MA; Shakhbazian IE; Sushkova NI; Smirnova GA; Obydena EA
    Pediatriia; 1991; (4):66-70. PubMed ID: 1712447
    [No Abstract]   [Full Text] [Related]  

  • 2. [Zinc and parlodel: the treatment potentials for retardation of growth and sexual development in nephropathies in adolescents].
    Kukhtevich AV; Ermolenko VM; Bunatian AF; Gitel' EP; Smirnova GA
    Ter Arkh; 1989; 61(10):106-12. PubMed ID: 2609255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathospermia in patients with glomerulonephritis and rheumatoid arthritis treated by immunodepressants: the possibilities of its correction with zinc and parlodel].
    Kukhtevich AV; Ermolenko VM; Bunatian AF; Gitel' EP; Smirnov GA; Nosova AA; Obydena EA
    Ter Arkh; 1991; 63(6):99-101. PubMed ID: 1948760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nephropathy-related disorders of physical and sexual development in girls: experience with successful stimulation by zinc, parlodel and norcolut].
    Kukhtevich AV; Ermolenko VM; Kuznetsova AI; Gitel' EP; Bunatian AF; Smirnova GA; Adnoral SA
    Ter Arkh; 1993; 65(6):54-8. PubMed ID: 8378851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunodepressive methods used in clinical medicine].
    Frei PC
    Rev Med Suisse Romande; 1974 Sep; 94(9):711-21. PubMed ID: 4548210
    [No Abstract]   [Full Text] [Related]  

  • 6. Rheumatoid arthritis (RA).
    Arthritis Rheum; 1970; 13(5):472-96. PubMed ID: 4921515
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunosuppressive therapy].
    Miescher PA; Gerebtzoff A; Lambert PH
    Ergeb Inn Med Kinderheilkd; 1974; 34(0):1-22. PubMed ID: 4154072
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug therapy. Immunosuppressive agents. I.
    Kaplan SR; Calabresi P
    N Engl J Med; 1973 Nov; 289(18):952-5. PubMed ID: 4582749
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunosuppressive therapy of collagen diseases. Case report].
    Miti L; Massei V; Sanguinetti CM
    Minerva Med; 1974 Mar; 65(24):1310-4. PubMed ID: 4831470
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunosuppressive therapy - review of up-to-date experience in the world and in our country].
    Jovanović D
    Med Arh; 1976; 30(5):307-15. PubMed ID: 1018520
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunosuppressive therapy in internal medicine].
    Scheiffarth F
    Bull Soc Sci Med Grand Duche Luxemb; 1973 Nov; 110(2):157-62. PubMed ID: 4149205
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problem of the treatment of amyloidosis (concerning the article by T.V. Chegaeva, O.M. Vinogradova and L.N. Kochubeĭ "Possibilities of using colchicine in rheumatoid arthritis with amyloidosis". Ter. arkh., No. 5, 1990, pp. 120-124)].
    Murav'ev IuV
    Revmatologiia (Mosk); 1991; (4):47-8. PubMed ID: 1805335
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunosuppressive agents].
    Lagrue G; Bariéty J; Druet P
    Acquis Med Recent; 1970; ():43-61. PubMed ID: 5526182
    [No Abstract]   [Full Text] [Related]  

  • 14. [Malignant affections occurring in rheumatoid arthritis].
    Treves R
    Presse Med; 1991 Apr; 20(13):583-4. PubMed ID: 1827901
    [No Abstract]   [Full Text] [Related]  

  • 15. [Renal side effects of treatment with cyclosporin A in rheumatoid arthritis and after bone marrow transplantation].
    Marbet UA; Graf U; Mihatsch MJ; Gratwohl A; Müller W; Thiel G
    Schweiz Med Wochenschr; 1980 Dec; 110(52):2017-20. PubMed ID: 7025192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressive agents in the basic therapy of visceral forms of rheumatoid arthritis in children].
    Kölle G; Stoeber E; Schöntag W
    Med Klin; 1972 Apr; 67(17):603-7. PubMed ID: 4624842
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunosuppressive agents. Conclusions].
    de Sèze S; Kahn MF
    Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):807-8. PubMed ID: 5152713
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathogenesis and prevention of bone loss in patients who have kidney disease and receive long-term immunosuppression.
    Cunningham J
    J Am Soc Nephrol; 2007 Jan; 18(1):223-34. PubMed ID: 17108315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications for the so-called immunosuppressive therapy. With special reference to the diffuse connective tissue diseases].
    Messini M; Guglielmi G; Ciavarelli F; Messini R
    Clin Ter; 1969 Jan; 48(2):105-44. PubMed ID: 5404642
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppressive therapy in rheumatoid arthritis.
    Rainer F
    Acta Med Austriaca; 1988; 15(5):137-40. PubMed ID: 3064524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.